Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 5:50 pm Sale | 13G | Aura Biosciences Inc. AURA | Lundbeckfond Invest A/S | 1,750,108 3.500% | -267,544 (-13.26%) | View |
| 2024-11-14 4:18 pm Sale | 13G | Aura Biosciences Inc. AURA | CITADEL ADVISORS LLC | 32,626 0.100% | -3,598,868 (-99.10%) | View |
| 2024-11-12 09:32 am Purchase | 13G | Aura Biosciences Inc. AURA | Adage Capital Management L.P. | 4,881,125 9.840% | 4,881,125 (New Position) | View |
| 2024-11-08 2:17 pm Unchanged | 13G | Aura Biosciences Inc. AURA | BlackRock Inc. BLK | 3,160,414 6.400% | 0 (Unchanged) | View |
| 2024-10-22 6:06 pm Purchase | 13G | Aura Biosciences Inc. AURA | BlackRock Inc. BLK | 3,160,414 6.400% | 3,160,414 (New Position) | View |
| 2024-02-14 4:57 pm Purchase | 13G | Aura Biosciences Inc. AURA | CITADEL ADVISORS LLC | 3,631,494 7.400% | 894,441 (+32.68%) | View |
| 2024-02-07 07:54 am Purchase | 13G | Aura Biosciences Inc. AURA | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,225,000 8.610% | 2,092,261 (+98.10%) | View |
| 2023-12-11 5:14 pm Purchase | 13G | Aura Biosciences Inc. AURA | EVENTIDE ASSET MANAGEMENT LLC | 5,802,682 11.820% | 3,551,314 (+157.74%) | View |
| 2023-11-09 4:34 pm Purchase | 13D | Aura Biosciences Inc. AURA | Matrix Capital Management Company LP | 6,922,870 14.100% | 1,560,000 (+29.09%) | View |
| 2023-02-14 1:30 pm Purchase | 13G | Aura Biosciences Inc. AURA | EVENTIDE ASSET MANAGEMENT LLC | 2,251,368 6.300% | 2,251,368 (New Position) | View |
| 2023-02-14 08:02 am Purchase | 13G | Aura Biosciences Inc. AURA | CITADEL ADVISORS LLC | 2,737,053 7.400% | 421,951 (+18.23%) | View |
| 2023-02-10 4:37 pm Sale | 13G | Aura Biosciences Inc. AURA | Arix Bioscience plc | 1,508,483 4.100% | -91,593 (-5.72%) | View |
| 2023-02-09 10:56 am Purchase | 13G | Aura Biosciences Inc. AURA | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,132,739 5.760% | 42,074 (+2.01%) | View |
| 2023-01-20 4:02 pm Sale | 13G | Aura Biosciences Inc. AURA | Chiesi Ventures Inc. | 1,218,803 3.300% | -406,268 (-25.00%) | View |
| 2022-12-15 4:40 pm Purchase | 13G | Aura Biosciences Inc. AURA | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,090,665 5.650% | 2,090,665 (New Position) | View |
| 2022-12-07 4:30 pm Purchase | 13D | Aura Biosciences Inc. AURA | Matrix Capital Management Company LP | 5,362,870 14.500% | 1,250,000 (+30.39%) | View |
| 2022-02-14 06:26 am Sale | 13G | Aura Biosciences Inc. AURA | CITADEL ADVISORS LLC | 2,315,102 7.900% | -2,656 (-0.11%) | View |
| 2022-02-11 5:59 pm Purchase | 13G | Aura Biosciences Inc. AURA | Advent Life Sciences LLP | 2,023,857 6.900% | 2,023,857 (New Position) | View |
| 2022-02-10 4:35 pm Purchase | 13G | Aura Biosciences Inc. AURA | Arix Bioscience plc | 1,600,076 29.210% | 91,593 (+6.07%) | View |
| 2022-01-26 4:06 pm Purchase | 13G | Aura Biosciences Inc. AURA | Lundbeckfond Invest A/S | 2,017,652 6.900% | 2,017,652 (New Position) | View |